Abstract
Anticancer treatment has become a research highlight in recent years. Despite several techniques have been developed and applied in the clinic, this area still meets great challenges in the construction of smart anticancer devices with accurate targeting, controlled release and microenvironment response properties. Most of the carbon-based materials are biocompatible, possessing abundant and tunable pore structures and particularly large surface areas. These properties make them suitable materials as drug carriers. In addition, some carbon-based materials are capable of absorbing near-infrared radiation (NIR) and have highly efficient photothermal effects. The generated heat in situ can be used to kill cancer cells in short time on the position. This review describes the recent and significant application of four kinds of carbon materials including carbon nanotubes, graphene, carbon dots and mesoporous carbon for drug delivery and photothermal therapy. After a short introduction of the structures and properties of these materials, the construction and application of these nanoplatforms in drug delivery, photothermal therapy or their combination will be summarized and discussed in depth. In addition, other carbon allotropes as drug carriers will be introduced briefly. Finally, the risk assessments and the perspectives and challenges of these materials used in cancer therapies are enclosed.
Keywords: Carbon-based nanomaterial, drug delivery, photothermal therapy, near-infrared, biomaterial, carbon allotropes.
Current Pharmaceutical Design
Title:Advanced Carbon-based Nanoplatforms Combining Drug Delivery and Thermal Therapy for Cancer Treatment
Volume: 24 Issue: 34
Author(s): Yanhong Xu, Yuling Shan, Hailin Cong, Youqing Shen and Bing Yu*
Affiliation:
- Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao 266071,China
Keywords: Carbon-based nanomaterial, drug delivery, photothermal therapy, near-infrared, biomaterial, carbon allotropes.
Abstract: Anticancer treatment has become a research highlight in recent years. Despite several techniques have been developed and applied in the clinic, this area still meets great challenges in the construction of smart anticancer devices with accurate targeting, controlled release and microenvironment response properties. Most of the carbon-based materials are biocompatible, possessing abundant and tunable pore structures and particularly large surface areas. These properties make them suitable materials as drug carriers. In addition, some carbon-based materials are capable of absorbing near-infrared radiation (NIR) and have highly efficient photothermal effects. The generated heat in situ can be used to kill cancer cells in short time on the position. This review describes the recent and significant application of four kinds of carbon materials including carbon nanotubes, graphene, carbon dots and mesoporous carbon for drug delivery and photothermal therapy. After a short introduction of the structures and properties of these materials, the construction and application of these nanoplatforms in drug delivery, photothermal therapy or their combination will be summarized and discussed in depth. In addition, other carbon allotropes as drug carriers will be introduced briefly. Finally, the risk assessments and the perspectives and challenges of these materials used in cancer therapies are enclosed.
Export Options
About this article
Cite this article as:
Xu Yanhong , Shan Yuling , Cong Hailin, Shen Youqing and Yu Bing *, Advanced Carbon-based Nanoplatforms Combining Drug Delivery and Thermal Therapy for Cancer Treatment, Current Pharmaceutical Design 2018; 24 (34) . https://dx.doi.org/10.2174/1381612825666181120160959
DOI https://dx.doi.org/10.2174/1381612825666181120160959 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Locally Advanced Cancer Cervix an Indian Perspective
Reviews on Recent Clinical Trials Dual Roles of Sulforaphane in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Developmental Phases of Anticancer Screening Models
Combinatorial Chemistry & High Throughput Screening Cyclooxygenase Inhibition and Mechanisms of Colorectal Cancer Prevention
Current Cancer Drug Targets Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry MCDCalc: Markov Chain Molecular Descriptors Calculator for Medicinal Chemistry
Current Topics in Medicinal Chemistry Neuroimaging of Cancer Patients for Psychosocial Support and Patient Care
Current Medical Imaging Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Synthesis and Biological Evaluation of Some Hydrazone Derivatives as Anti-inflammatory Agents
Letters in Drug Design & Discovery Structural Characterization, Homology Modeling and Docking Studies of ARG674 Mutation in MyH8 Gene Associated with Trismus-Pseudocamptodactyly Syndrome
Letters in Drug Design & Discovery TRP Channels in Respiratory Pathophysiology: the Role of Oxidative, Chemical Irritant and Temperature Stimuli
Current Neuropharmacology 3D-QSAR Modeling of Non-peptide Antagonists for the Human Luteinizing Hormone-releasing Hormone Receptor
Medicinal Chemistry Drug Targets in Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection
Infectious Disorders - Drug Targets Synthesis, Biological Activity of Thiazolidinones Bearing Indoline Moiety and Isatin Based Hybrids
Mini-Reviews in Organic Chemistry Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A
Current Cancer Drug Targets Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Current Cancer Drug Targets Strategies to Improve the Functions and Redox State of the Immune System in Aged Subjects
Current Pharmaceutical Design Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses
Current Cancer Drug Targets Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity
Current Medicinal Chemistry